Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-13

Clinical Trial Update: Study of Tarceva and Targretin Oral Capsules in Patients With Advanced Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update of Tarceva and Targretin oral capsules in advanced non-small-cell lung cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tarceva (erlotinib)
  • Targretin (bexarotene)

Snippet

Sponsor: Konstantin Dragnev | Conditions: Carcinoma, Non-small-cell Lung | Phase 2 | Status: COMPLETED | Results posted: 2018-11-13